As Moderna maps out a more cautious future amid lower-than-expected sales of its current products, the company is bolstering ...

The 2024-25 Premier League’s chase for European qualification is thick and heavy, with as many as a dozen teams harboring hope of making it to the next season’s UEFA Champions League, Europa League, ...

Robert F. Kennedy Jr., President Trump’s nominee to be health secretary, would have oversight power over the vaccine’s maker, Merck, if confirmed. By Christina Jewett and Sheryl Gay Stolberg ...

Merck desperately needs Moderna's mRNA-based ... 13), prior to presenting at the 43 rd Annual J.P. Morgan Healthcare Conference, Moderna released preliminary 2024 sales and updated 2025 guidance.

Exclusive-Kennedy Played Key Role in Vaccine Case Against Merck By Dan Levine and Mike Spector (Reuters) - Robert F. Kennedy Jr. played an instrumental role in organizing mass litigation against ...

Jan 18 (Reuters) - Robert F. Kennedy Jr. played an instrumental role in organizing mass litigation against drugmaker Merck over its Gardasil vaccine, a strategy that faces its first test in a Los ...

Merck stock (NYSE: MRK) lost about 10% in 2024, underperforming the broader S&P 500 index, which gained 23% for the year. Despite strong performances from other pharmaceutical giants like Eli ...

The conference is scheduled for January 19-20, 2025, at the Vancouver Convention Centre West. Gold Terra invites shareholders and the investment community to visit us at Booth #316. Complimentary ...

The conference is scheduled for January 19-20, 2025, at the Vancouver Convention Centre West. Gold Terra invites shareholders and the investment community to visit us at Booth #316. Complimentary ...

WEST LAFAYETTE, Ind. — Purdue University, in collaboration with Eli Lilly and Company and Merck & Co. Inc., announced Friday (Jan. 17) the launch of the Young Institute Pharmaceutical Manufacturing ...

2025--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, will hold its fourth-quarter and full-year 2024 sales and earnings conference call with ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, will hold its fourth-quarter and full-year 2024 sales and earnings conference call with institutional investors and ...